CRBP · Corbus Pharmaceuticals Holdings, Inc.

$11.33 +0.05 (+0.44%)

Market Cap

$206.37M

19.34M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
8-K	2026-07-06	2026-07-02
Investor Event Transcript	2026-06-04	2026-06-30
8-K	2026-05-26	—
Investor Event Transcript	2026-05-26	2026-06-30
8-K	2026-05-21	2026-05-19
8-K	2026-05-14	2026-05-13
10-Q	2026-05-12	2026-03-31
8-K	2026-05-12	—
8-K	2026-04-16	2026-04-15
8-K	2026-04-14	—
8-K	2026-04-07	2026-04-01
DEF 14A	2026-04-02	2026-04-01
8-K	2026-03-09	—
10-K	2026-03-09	2025-12-31
8-K	2026-02-25	—
8-K	2026-01-12	—
8-K	2025-12-18	2025-12-12
8-K	2025-12-11	—
8-K	2025-11-12	—
10-Q	2025-11-12	2025-09-30
8-K	2025-11-03	2025-10-30
8-K	2025-10-30	—
8-K	2025-10-20	2025-10-18
8-K	2025-09-16	—
10-Q	2025-08-05	2025-06-30
8-K	2025-08-05	—
8-K	2025-05-19	2025-05-15
8-K	2025-05-06	—
10-Q	2025-05-06	2025-03-31
DEF 14A	2025-04-01	2025-05-15
8-K	2025-03-21	2025-03-20
8-K	2025-03-18	2025-03-13
10-K	2025-03-11	2024-12-31
8-K	2025-03-11	—
8-K	2025-02-14	—
8-K	2024-12-03	—
8-K	2024-11-15	—
8-K	2024-11-07	—
10-Q	2024-11-07	2024-09-30
8-K	2024-11-04	—
8-K	2024-09-03	2024-08-29
8-K	2024-08-20	2024-08-15
8-K	2024-08-06	—
10-Q	2024-08-06	2024-06-30
8-K	2024-08-06	—
8-K	2024-06-17	2024-06-14
8-K	2024-06-03	2024-06-01
8-K	2024-05-20	2024-05-16

Showing 1–50 of 149 filings

Key facts CIK 1595097 CUSIP 21833P301 13F (30d) 90 filings 89 filers Visit website Investor relations